Ajay J. Kirtane, MD, Associate Professor of Medicine at Columbia University Medical Center in New York, talks with DocWire News about clinical decision-making for patients presenting with angina, as well as how he approaches selecting the optimal treatment modalities for this patient population. According to Dr. Kirtane, the choice of modality ultimately depends greatly on the individual patient, their individual disease state and its severity, their personal preferences, whether they’re stable or unstable. Patients with milder forms of disease, medical therapy may be beneficial, while rapidly worsening symptoms may benefit from more invasive strategies.
Today's Top 5
5. The Season of Giving Cometh
Season of giving got more generous. Isn't it @PCRonline ?#EAPCI Education & training Grants offer €25,000 for a year's training in an interventionalist centre of excellence. New: 50% of grants will be allocated to women interventionalists— European Cardiology (@escardio) December 10, 2018
Apply by 15 Jan https://t.co/9hGiwfuF3V pic.twitter.com/ht8yvcOrNb
4. The Scale of Atrial Fibrillation Inheritability
3. How Do YOU Treat?
Great ?-comes up all the time. The new cholesterol guidelines suggest that CAC score often useful in that intermediate risk patient-I will usually calculate the ASCVD risk score, and proceed to CAC if it appears likely that the result may move me across a treatment threshold. https://t.co/PdLT8woINZ— Kim Eagle (@keaglemd) December 11, 2018